March 22, 2024Spinal CordOpen Access

Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT

View Full Paper

Ask AI

Bookmark

Abstract

This was a sub-group analysis of a multicentre, randomised, placebo-controlled, double-blind trial (ECLISP trial) OBJECTIVES: To assess the efficacy of a probiotic containing at least 6.5 × 10

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wong et al. (2024) studied this question.

synapsesocial.com/papers/68e72b9db6db6435876a582b https://doi.org/10.1038/s41393-024-00983-w

View Full Paper

Ask AI

Bookmark

Abstract

This was a sub-group analysis of a multicentre, randomised, placebo-controlled, double-blind trial (ECLISP trial) OBJECTIVES: To assess the efficacy of a probiotic containing at least 6.5 × 10

Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT

Abstract

Discussion

Cite This Study

Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT

Abstract

Discussion

Cite This Study

Keep reading

Keep reading